Short Description Elixirgen Therapeutics develops mrna & ipsc therapies to address aging and extend healthy lifespan.
Description Elixirgen Therapeutics is a leading biotechnology innovator in the longevity ecosystem, focused on mrna & ipsc therapies as a core strategy for combating age-related decline. The company leverages advances in genetic therapy and partners with premier research institutions to transform scientific discoveries into real-world interventions. With a mission to add healthy years to life, Elixirgen Therapeutics aims to bring evidence‑based solutions from bench to patients and consumers worldwide.
Address 855 N Wolfe St, Suite 506, Baltimore, MD, USA